Squarepoint Ops LLC Invests $405,000 in Orthofix Medical Inc. (NASDAQ:OFIX)

Squarepoint Ops LLC bought a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 30,562 shares of the medical device company’s stock, valued at approximately $405,000. Squarepoint Ops LLC owned 0.08% of Orthofix Medical at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of OFIX. Boone Capital Management LLC bought a new stake in shares of Orthofix Medical during the 4th quarter valued at about $6,740,000. Glenview Capital Management LLC purchased a new position in shares of Orthofix Medical during the 4th quarter worth approximately $6,740,000. BNP Paribas Financial Markets raised its position in shares of Orthofix Medical by 190.5% in the 1st quarter. BNP Paribas Financial Markets now owns 34,602 shares of the medical device company’s stock worth $502,000 after acquiring an additional 22,690 shares in the last quarter. Mutual of America Capital Management LLC lifted its stake in shares of Orthofix Medical by 15.3% in the 1st quarter. Mutual of America Capital Management LLC now owns 175,671 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 23,324 shares during the period. Finally, GSA Capital Partners LLP bought a new stake in shares of Orthofix Medical during the first quarter valued at approximately $921,000. 89.76% of the stock is currently owned by institutional investors.

Orthofix Medical Trading Down 0.5 %

NASDAQ:OFIX opened at $15.00 on Friday. Orthofix Medical Inc. has a one year low of $9.57 and a one year high of $17.67. The company’s 50-day simple moving average is $16.21 and its 200 day simple moving average is $14.86. The firm has a market capitalization of $562.94 million, a P/E ratio of -4.44 and a beta of 1.05. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.48 and a quick ratio of 1.13.

Orthofix Medical (NASDAQ:OFIX) last released its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.58). Orthofix Medical had a negative net margin of 15.61% and a negative return on equity of 20.68%. The business had revenue of $198.62 million during the quarter, compared to the consensus estimate of $195.75 million. As a group, analysts forecast that Orthofix Medical Inc. will post -2.13 EPS for the current fiscal year.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.